Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MeVis Medical Solutions AGFRA:M3V 73 3-1 Month Momentum % is 5.26% as of Aug. 27, 2026. GuruFocus rates FRA:M3V with a GF Score™ of 73/100 and a GF Value™ of €22.32 (Fairly Valued). The stock has 5 warning signs investors should review. Among 669 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 68.91% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-27), MeVis Medical Solutions AG's 3-1 Month Momentum % is 5.26%.
The industry rank for MeVis Medical Solutions AG's 3-1 Month Momentum % or its related term are showing as below:
FRA:M3V's 3-1 Month Momentum % is ranked better than 68.91% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: -2.17
vs FRA:M3V: 5.26
MeVis Medical Solutions AG (FRA:M3V) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
MeVis Medical Solutions AG 3-1 Month Momentum % Related Terms
FRA:M3V vs VEEV, BTSG, HQY: 3-1 Month Momentum % Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's 3-1 Month Momentum % falls into.
MeVis Medical Solutions AG (FRA:M3V) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG (FRA:M3V) has a 3-1 Month Momentum % of 5.26% as of Aug. 27, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on MeVis Medical Solutions AG and its competitors. According to the industry distribution chart, MeVis Medical Solutions AG ranks #208 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 31.1%.
Is MeVis Medical Solutions AG's 3-1 Month Momentum % too high?
MeVis Medical Solutions AG's current 3-1 Month Momentum % is 5.26%. Based on the distribution chart, MeVis Medical Solutions AG ranks #208 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MeVis Medical Solutions AG has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's 3-1 Month Momentum % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #208 out of 669 companies for 3-1 Month Momentum %. This puts MeVis Medical Solutions AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on MeVis Medical Solutions AG and its competitors. MeVis Medical Solutions AG's current 3-1 Month Momentum % is 5.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
Based on GuruFocus' analysis, MeVis Medical Solutions AG (FRA:M3V) is currently considered Fairly Valued. The stock's GF Value™ is €22.32, compared to a current price of €23.40 — trading 4.8% above its estimated fair value. The current 3-1 Month Momentum % is 5.26%. MeVis Medical Solutions AG's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current 3-1 Month Momentum % is 5.26% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.40 is trading 4.8% above its estimated GF Value™ of €22.32.
GuruFocus considers MeVis Medical Solutions AG to be Fairly Valued.
Key valuation signals for FRA:M3V:
3-1 Month Momentum %: 5.26%
GF Value™: €22.32 vs. price of €23.40 (4.8% above fair value)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
73GF Score
Get the complete analysis for FRA:M3V
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
